Skip to Content

717 5.4 WATSON (Yohimbine Hydrochloride 5.4 mg)

Pill with imprint 717 5.4 WATSON is , and has been identified as Yohimbine Hydrochloride 5.4 mg. It is supplied by Watson Pharmaceuticals.

Yohimbine is used in the treatment of erectile dysfunction; sexual dysfunction, ssri induced and belongs to the drug class impotence agents. FDA has not classified the drug for risk during pregnancy. Yohimbine 5.4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 717 5.4 WATSON

Yohimbine Hydrochloride

Imprint:
717 5.4 WATSON
Strength:
5.4 mg
Availability:
Prescription only
Drug Class:
Impotence agents
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
National Drug Code (NDC):
52544-0717

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide